Please be aware that this website relies on the use of cookies to function correctly and involves some cookies being downloaded onto your device. By continuing to use this website, you agree to our use of these cookies. This helps us to improve the content of the website so that it is more useful and relevant to you. For more information please see our Privacy Policy.


Patient Access to Cancer care Excellence

A Global Vision

Faster steps forward: towards cures for cancer and access to best treatment and care for individual patients.

Learn more about PACE

Michael D. Peake, M.D.

Dr. Peake is a Consultant and Senior Lecturer in Respiratory Medicine for the University Hospitals of Leicester, based at the Glenfield Hospital, Leicester, UK. He is Clinical Lead for the National Cancer Intelligence Network (NCIN) and for the National Lung Cancer Audit Programme (NLCA), run jointly between the NHS Information Centre and the Royal College of Physicians, where he is Associate Director of the Clinical Effectiveness and Evaluation Unit. He is National Clinical Lead for NHS Cancer Improvement, with a particular remit for Lung Cancer plus the National Awareness and Early Diagnosis Initiative (NAEDI). He is co-chair of the DH’s Lung Cancer and Mesothelioma Advisory Group. He is also a member of the steering group of the British Thoracic Oncology Group, vice-chair of Mesothelioma UK, sits on the NCRI’s Lung Clinical Study Group and is a member of the DH’s National Advisory Group for Clinical Audit and Enquiries. He has been involved in the development and implementation of national cancer policy in the UK since the late 1990s. His major interests are in early diagnosis and improving outcomes for cancer patients by proper service configuration, supported by good clinical outcome data.